View Item 

Show simple item record

Donor Screening for Human T-cell Lymphotrophic Virus 1/2: Changing Paradigms for Changing Testing Capacity
dc.contributor.authorKaul, D. R.en_US
dc.contributor.authorTaranto, S. E.en_US
dc.contributor.authorAlexander, C.en_US
dc.contributor.authorCovington, S.en_US
dc.contributor.authorMarvin, M.en_US
dc.contributor.authorNowicki, M.en_US
dc.contributor.authorOrlowski, J. P.en_US
dc.contributor.authorPancoska, C.en_US
dc.contributor.authorPruett, Timothy L.en_US
dc.contributor.authorIson, Michael G.en_US
dc.date.accessioned2010-06-01T21:49:35Z
dc.date.available2010-06-01T21:49:35Z
dc.date.issued2010-02en_US
dc.identifier.citationKaul, D. R.; Taranto, S.; Alexander, C.; Covington, S.; Marvin, M.; Nowicki, M.; Orlowski, J.; Pancoska, C.; Pruett, T. L.; Ison, M. G. (2010). "Donor Screening for Human T-cell Lymphotrophic Virus 1/2: Changing Paradigms for Changing Testing Capacity." American Journal of Transplantation 10(2): 207-213. <http://hdl.handle.net/2027.42/74865>en_US
dc.identifier.issn1600-6135en_US
dc.identifier.issn1600-6143en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/74865
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=19839982&dopt=citationen_US
dc.format.extent82587 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Incen_US
dc.rights© 2010 American Society of Transplantation and the American Society of Transplant Surgeonsen_US
dc.subject.otherDonor Evaluationen_US
dc.subject.otherDonor-to-Host Transmissionen_US
dc.subject.otherInfectious Diseasesen_US
dc.subject.otherViral Infectionen_US
dc.titleDonor Screening for Human T-cell Lymphotrophic Virus 1/2: Changing Paradigms for Changing Testing Capacityen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelMedicine (General)en_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Internal Medicine, Division of Infectious Diseases, University of Michigan Medical School, Ann Arbor, MIen_US
dc.contributor.affiliationotherUnited Network for Organ Sharing, Richmond, VAen_US
dc.contributor.affiliationotherLiving Legacy Foundation of MD, Baltimore, MDen_US
dc.contributor.affiliationotherDepartment of Surgery, Division of Transplantation, Jewish Hospital, Louisville, KYen_US
dc.contributor.affiliationotherNational Institute of Transplantation, Los Angeles, CAen_US
dc.contributor.affiliationotherCenter for Donation and Transplant, Albany, NYen_US
dc.contributor.affiliationotherLABS-Inc., Centennial, COen_US
dc.contributor.affiliationotherDepartment of Surgery, Division of Transplantation, University of Virginia Health Systems, Charlottesville, VAen_US
dc.contributor.affiliationotherDepartment of Medicine, Division of Infectious Diseases and Department of Surgery, Division of Organ Transplantation, Feinberg School of Medicine, Northwestern University, Chicago, ILen_US
dc.identifier.pmid19839982en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/74865/1/j.1600-6143.2009.02867.x.pdf
dc.identifier.doi10.1111/j.1600-6143.2009.02867.xen_US
dc.identifier.sourceAmerican Journal of Transplantationen_US
dc.identifier.citedreferenceBlattner WA, Saxinger C, Riedel D et al. A study of HTLV-I and its associated risk factors in Trinidad and Tobago. J Acquir Immune Defic Syndr 1990; 3: 1102 – 1108.en_US
dc.identifier.citedreferenceGlynn SA, Kleinman SH, Schreiber GB et al. Trends in incidence and prevalence of major transfusion-transmissible viral infections in U.S. blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS). JAMA 2000; 284: 229 – 235.en_US
dc.identifier.citedreferenceManns A, Wilks RJ, Murphy EL et al. A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion. Int J Cancer 1992; 51: 886 – 891.en_US
dc.identifier.citedreferenceMartin-Davila P, Fortun J, Lopez-Velez R et al. Transmission of tropical and geographically restricted infections during solid-organ transplantation. Clin Microbiol Rev 2008; 21: 60 – 96.en_US
dc.identifier.citedreferenceMurphy E, Roucoux D. The epidemiology and disease outcomes of human T-lymphotropic virus type II. AIDS Rev 2004; 6: 144 – 154.en_US
dc.identifier.citedreferenceNowicki MJ, Matsuoka L, Brucal D et al. High seroprevalence of anti-HTLV-I/II antibodies among solid organ donors necessitates confirmatory testing. Transplantation 2006; 82: 1210 – 1213.en_US
dc.identifier.citedreferenceShames BD, D'Alessandro AM, Sollinger HW. Human T-cell lymphotrophic virus infection in organ donors: A need to reassess policy? Am J Transplant 2002; 2: 658 – 663.en_US
dc.identifier.citedreference8.  U.S. Department of Health and Human Services. Organ Procurement and Transplantation Network. Available from: http://optn.transplant.hrsa.gov/policiesAndBylaws/policies.asp. Accessed April 23, 2009.en_US
dc.identifier.citedreference9.  US Food and Drug Administrations. Center for Biologics Evaluation and Research. [cited 2009 April 24]; Available from: http://www.fda.gov/cber/tissue/prod.htm#approveden_US
dc.identifier.citedreferenceIson MG, Pruett T, Teperman L. Current practices and future challenges: A survey reported by the OPTN/UNOS Ad Hoc Disease Transmission Advisory Committee. In: American Transplantation Congress: 385 Abstract. Boston, 2009.en_US
dc.identifier.citedreference11.  Package Insert: Abbott PRISM HTLV-II/HTLV-II.en_US
dc.identifier.citedreference12.  Package Insert: Abbott HTLV-I/HTLV-II EIA.en_US
dc.identifier.citedreference13.  Package Insert: BioMerieux Vironostika HTLV-I/II Microelisa System.en_US
dc.identifier.citedreferenceNakatsuji Y, Sugai F, Watanabe S et al. HTLV-I-associated myelopathy manifested after renal transplantation. J Neurol Sci 2000; 177: 154 – 156.en_US
dc.identifier.citedreferenceRemesar MC, del Pozo AE, Pittis MG, Mangano AM, Sen L, Briones L. Transmission of HTLV-I by kidney transplant. Transfusion 2000; 40: 1421 – 1422.en_US
dc.identifier.citedreferenceToro C, RodÉs B, Poveda E, Soriano V. Rapid development of subacute myelopathy in three organ transplant recipients after transmission of human T-cell lymphotropic virus type I from a single donor. Transplantation 2003; 75: 102 – 104.en_US
dc.identifier.citedreferenceHoshida Y, Li T, Dong Z et al. Lymphoproliferative disorders in renal transplant patients in Japan. Int J Cancer 2001; 91: 869 – 875.en_US
dc.identifier.citedreferenceKawano N, Shimoda K, Ishikawa F et al. Adult T-cell leukemia development from a human T-cell leukemia virus type I carrier after a living-donor liver transplantation. Transplantation 2006; 82: 840 – 843.en_US
dc.identifier.citedreferenceNakamura N, Arakaki Y, Sunagawa H et al. Influence of immunosuppression in HTLV-1-positive renal transplant recipients. Transpl Proc 1998; 30: 1324 – 1326.en_US
dc.identifier.citedreferenceTanabe K, Kitani R, Takahashi K et al. Long-term results in human T-cell leukemia virus type 1-positive renal transplant recipients. Transpl Proc 1998; 30: 3168 – 3170.en_US
dc.identifier.citedreferenceMarvin MR, Brock GN, Kwarteng K et al. Increasing utilization of human T-cell lymphotropic virus (+) donors in liver transplantation: Is it safe? Transplantation 2009; 87: 1180 – 1190.en_US
dc.identifier.citedreferenceClaquin J, Romano P, Noury D et al. Human T lymphotropic virus 1--2 positive antibodies in potential organ donors in France. Transpl Proc 1996; 28: 189 – 190.en_US
dc.identifier.citedreferenceToro C, Benito R, Aguilera A et al. Infection with human T lymphotropic virus type I in organ transplant donors and recipients in Spain. J Med Virol 2005; 76: 268 – 270.en_US
dc.identifier.citedreferenceHarrington WJ Jr., Ucar A, Gill P et al. Clinical spectrum of HTLV-I in south Florida. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8: 466 – 473.en_US
dc.identifier.citedreferenceLevine PH, Dosik H, Joseph EM et al. A study of adult T-cell leukemia/lymphoma incidence in central Brooklyn. Int J Cancer 1999; 80: 662 – 666.en_US
dc.identifier.citedreference26.  Personal communication, National Institute of Transplantation, Inc., 2009.en_US
dc.identifier.citedreference27.  Personal communication, Carol Pancoska, LABS-Inc., 2009.en_US
dc.identifier.citedreferenceNakamura N, Tamaru S, Ohshima K, Tanaka M, Arakaki Y, Miyauchi T. Prognosis of HTLV-I-positive renal transplant recipients. Transpl Proc 2005; 37: 1779 – 1782.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1600-6143.2009.02867.x.pdf
Size:
80.65KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.